FIELD: medicine, laboratory diagnostics. SUBSTANCE: one should apply plasma dilution with a standard buffer solution at 1:20 - 1:50, copper-induced oxidation is carried out by adding 0.1 ml aqueous solution of CuSO4•5H2O at concentration of 20 mcM CuSO4 to 2 ml diluted plasma, the mixture obtained should be incubated at 37 C at periodic mixing, 24 h later one should register obtained quantity of products reacting with thiobarbituric acid at recalculation for 1 ml undiluted plasma to compare to the value of blood plasma oxidizing resistance established for healthy patients. The method is very simple and available under conditions of clinical practice. EFFECT: higher sensitivity. 4 dwg, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR EVALUATING THE DEGREE OF THERAPY AND DETERMINING THE INDICATIONS FOR ANTIOXIDANT THERAPY IN PATIENTS WITH ISCHEMIC CARDIAC DISEASE | 2001 |
|
RU2192643C1 |
ESTIMATE OF DISEASE SEVERITY AND INDICATIONS FOR ANTIOXIDANT THERAPY IN PATIENTS SUFFERING FROM CHRONIC CEREBRAL ISCHEMIA | 2007 |
|
RU2357253C2 |
METHOD FOR RAPID DETERMINATION OF RESISTANCE TO LDL OXIDATION OF HUMAN SERUM | 2015 |
|
RU2578027C1 |
INSTANT SEVERITY DIAGNOSIS OF ISCHEMIC HEART DAMAGE IN PATIENT WITH CHRONIC HEART DISEASE AND PROPENSITY FOR PROGRESSING ATHEROSCLEROSIS | 2009 |
|
RU2408019C1 |
METHOD OF ESTIMATING EFFICIENCY OF ISCHEMIC DISEASE TREATMENT | 1995 |
|
RU2122732C1 |
METHOD OF DETERMINING OXIDATIVE MODIFICATION OF FIBRINOGEN IN BLOOD PLASMA BY CONTENT OF CARBONYL GROUPS IN FIBRINOUS CLOT | 2014 |
|
RU2595806C2 |
METHOD FOR EVALUATING RISK OF CLINICAL COMPLICATIONS OF ATHEROSCLEROSIS | 2011 |
|
RU2498307C2 |
METHOD FOR CIRCULATING DESIALYLATED LOW DENSITY LIPOPROTEIDS CONTENT ESTIMATION | 2015 |
|
RU2623879C2 |
METHOD FOR DETERMINING RESISTANCE TO LOW DENSITY BLOOD SERUM LIPOPROTEIN OXIDATION | 1997 |
|
RU2151403C1 |
METHOD OF PROGNOSIS OF ISCHEMIC HEART DISEASE COURSE | 1995 |
|
RU2102756C1 |
Authors
Dates
2003-05-20—Published
2001-04-10—Filed